Trial intelligence / Profile preview

Effect of lisinopril on endothelial glycocalyx and albuminuria in type 1 diabetes

2008-002610-21Phase 4Active

Sponsor
Amsterdam University Medical Center
Start
May 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of lisinopril in diabetes mellitus type 1 (T1D) and diabetic glomerulosclerosis, sponsored by Amsterdam University Medical Center. Primary endpoint: Change in microvascular glycocalyx thickness. Started May 2008; status: active.

02

Drugs

lisinopril
03

Conditions

diabetes mellitus type 1 (T1D)diabetic glomerulosclerosis

Beyond the preview

Go deeper on 2008-002610-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-002610-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call